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Abstract: Furosemide loaded electrospun fibers were prepared for buccal administration, with the
aim of improving the oral bioavailability of the poorly soluble and permeable crystalline drug,
which can be achieved by the increased solubility and by the circumvention of the intensive first
pass metabolism. The water soluble hydroxypropyl cellulose (HPC) was chosen as a mucoadhesive
polymer. In order to improve the electrospinnability of HPC, poly (vinylpyrrolidone) (PVP) was
used. During the experiments, the total polymer concentration was kept constant at 15% (w/w), and
only the ratio of the two polymers (HPC-PVP = 5:5, 6:4, 7:3, 8:2, 9:1) was changed. A combination of
rheological measurements with scanning electron microscopic morphological images of electrospun
samples was applied for the determination of the optimum composition of the gels for fiber formation.
The crystalline–amorphous transition of furosemide was tracked by Fourier transform infrared
spectroscopy. A correlation was found between the rheological properties of the polymer solutions
and their electrospinnability, and the consequent morphology of the resultant samples. With
decreasing HPC ratio of the system, a transition from the spray-dried droplets to the randomly
oriented fibrous structures was observed. The results enable the determination of the polymer ratio
for the formation of applicable quality of electrospun fibers.
Keywords: furosemide; electrospinning; hydroxypropyl cellulose; poly (vinylpyrrolidone); storage
and loss moduli; scanning electron microscopic images
1. Introduction
Electrospinning is an emerging technology by which mats of micro- and nanofibers can be
produced using an electrostatically driven jet of polymer solution or melt. A wide variety of micro- and
nanofibers have been formulated by this process using several natural and synthetic polymers. The use
of electrospinning for the fabrication of drug-loaded nanofibrous scaffolds is a promising alternative
for developing delivery systems of high efficiency. Many types of drugs can be easily incorporated into
electrospun materials. Along with the changes of the morphology, the porosity and the composition of
the nanofibers, and the release profile of the incorporated drug can be fine-tuned [1].
Furosemide is used as a loop diuretic in treatment of hypertension, and in renal, cardiac, and
hepatic oedematous status. It belongs to the BCS (Biopharmaceutical Classification System) IV class,
due to its poor water soluble properties (5–20 µg/mL at pH = 7) and low membrane permeability,
and thus, poor bioavailability [2–7]. The low and variable absorption from the stomach and upper
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part of the duodenum in the gastrointestinal tract, and presence of intestinal efflux proteins, make its
therapeutic use difficult. The reason of the slight absorption is partly the presence of the intestinal
efflux proteins, mentioned previously, and in part the ionization (the ionization is 94.06% at pH = 5 and
99.97% at pH = 7.4). In the ileum, the expression of the MDR1 (multidrug resistance P-glycoprotein;
PgP) efflux protein is much more than in the jejunum. Therefore, the absorption in the ileum is 2.5 times
slower than in the jejunum [8].
Furosemide is commonly applied in oral and intravenous therapies, but many systemic side
effects occur during the traditional administrations, like polyuria, mouth drying, dizziness, and gastric
problems [9]. Because of the low oral bioavailability and the slow onset of action (even 60 min) the
administration of the conventional tablets is not appropriate in emergency situations [10].
The registered furosemide containing medicines are mostly tablets (40, 80, 500 mg) and injections
in Hungary [11]. However, several research groups deal with developing new formulations, owing
to the enhancement of the water solubility of the furosemide and its consequent bioavailability.
Some of these formulations are fast dissolving tablets [10], supramolecular complexes [4,7], melt
extrusion methods [12], micro/nanoparticles for drug delivery [13], mucoadhesive microspheres [3],
and halloysites [14]. The primary focus of the recent studies was to improve the solubility and
permeability of the BCS IV drugs by the use of special formulation strategies.
An alternative formulation of active ingredients with poor water solubility and low bioavailability,
is to make a mucoadhesive buccal drug delivery system. It is also a good opportunity to use the drugs
in emergency situations without invasive administration. The transmucosal formulations could be
an option in the case of enhancing the bioavailability of the furosemide. Using buccal administration,
it can be possible to circumvent the first pass metabolism. As consequence of the rich vascularization
of the buccal mucosa, the drug can be easily taken to the systemic circulation. On the other hand, the
buccal epithelium has a barrier function, which makes penetration difficult, therefore, it is necessary
the use of permeation enhancers during the formulation [15–17].
Electrospun nanofibrous drug delivery systems could be promising alternative forms with their
advantages, like high porosity, high surface to volume ratio, and the transition of crystalline to
amorphous form, thus enhancing solubility [18–20].
The aim of the present study was to prepare amorphous furosemide-loaded mucoadhesive
fibrous formulations containing solubilizer, which could also act as a penetration enhancer for
buccal application. Aqueous solution was used for the electrospinning to generate nanofibers of
environmentally friendly conditions, and consequently, there was no need to define the residual
solvent content. In order to select the optimum composition, the authors provide detail and adequate
characterization of the fibers with rheology, size, morphology, and solid-state characterization.
The correlation between the fiber forming ability and the rheological properties of the initial
drug-containing HPC-PVP solutions and their electrospinnability, and the consequent morphology of
the resultant samples, was also determined.
2. Materials and Methods
2.1. Materials
Hydroxypropyl cellulose (Klucel EXF Pharm, Ashland, Covington, KY, USA; Mw ~80,000, the
moles of substitution = 3.8), poly(vinylpyrrolidone) (Kollidon 90 F, BASF, Ludwigshafen, Germany;
Mw ~1,000,000–1,500,000) as polymers (Figure 1b,c), trolamine (Ph. Eur., Molar Chemicals, Budapest,
Hungary) as surfactant, and purified water was used as solvent for the polymers. Furosemide (Ph. Eur.,
Figure 1a) was used as model drug from the BCS IV class.
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Figure 1. Chemical structure of furosemide (a) and the structural units of fiber forming polymers  
(b: HPC, c: PVP). 
2.2. Preparation of Furosemide Containing HPC-PVP Gels 
The stock solution of furosemide was prepared by adding 0.2 furosemide into a dark beaker, 
and it was dissolved with 17.2 g purified water in a few minutes under magnetic stirring by adding 
0.3 g trolamine as solubilizer. The gels were prepared by using the furosemide solution in each case, 
and a different added amount of PVP. These compositions were being mixed at room temperature (T 
= 25 °C), until they had reached a totally homogenous condition. The necessary amount of HPC was 
added in small portions to the prepared drug loading PVP gels during stirring, also at room 
temperature (T = 25 °C) to achieve the homogeneity. The total polymer concentration of the gels was 
15 wt %, but the w/w ratio of the applied two polymers was different. The different HPC-PVP ratios 
were 5:5, 6:4, 7:3, 8:2, 9:1. 
2.3. Preparation of the Physical Mixtures 
For the fourier transform infrared (FT-IR) measurements the powder physical mixtures of the 
gel components (containing furosemide, polymers, and surfactant) were prepared and homogenized 
by stirring for 5 min in a porcelain mortar. 
2.4. Rheological Properties of the Gels 
Kinexus Pro Rheometer (Malvern Instruments Ltd., Malvern, UK) was used for measuring the 
rheological properties of the prepared gels at room temperature (T = 25 ± 0.1 °C). During the 
measurement, data were registered with software of rSpace for Kinexus Pro 1.3 (Malvern 
Instruments Ltd., Malvern, UK). Parallel plates geometry (diameter: 50 mm) was applied during the 
tests; the gap between the plates was 0.0300 mm. Elastic (G’) and viscous moduli (G”) were 
determined by oscillatory rheological tests. The oscillatory shear measurements were performed at 
amplitude within the linear region, which was chosen to 30% within the viscoelastic region, and the 
frequency was in the range of 0.1–10 s−1. Three parallel measurements were done with each gel in 
both tests. 
2.5. Electrospinning 
The nanofibers were prepared by electrospinning at room temperature (25 °C). The gels were 
put into syringes, after that, silicon tubes with needles (internal diameter: 1.2) on their ends were 
connected to the syringes. High voltage was applied (25 kV) at 15 cm collector-needle distance. The 
flow rate was 0.3 mL/h during the spinning process. The prepared fibers and droplets were dried at 
room temperature during the electrospinning process. 
2.6. ATR-FTIR (Attenuated Total Reflectance-Fourier Transform Infrared) Spectroscopy Measurements 
The ATR-FTIR spectra of the fibers, physical mixtures and raw substances were measured by 
using Jasco FT/IR-4200 spectrophotometer (Jasco Inc., Easton, MD, USA), which was equipped with 
Jasco ATR PRO470-H single reflection accessory. The spectra were collected over a wavenumber 
Figure 1. Chemical structure of furosemide (a) and the structural units of fiber forming polymers
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2.2. Preparation of Furosemide Containing HPC-PVP Gels
The stock solution of furosemide was prepared by adding 0.2 furosemide into a dark beaker, and
it was dissolved with 17.2 g purified water in a few minutes under magnetic stirring by adding 0.3 g
trolamine as solubilizer. The gels were prepared by using the furosemide solution in each case, and a
different added amount of PVP. These compositions were being mixed at room temperature (T = 25 ◦C),
until they had reached a totally homogenous condition. The necessary amount of HPC was added
in small portions to the prepared drug loading PVP gels during stirring, also at room temperature
(T = 25 ◦C) to achieve the homogeneity. The total polymer concentration of the gels was 15 wt %, but
the w/w ratio of the applied two polymers was different. The different HPC-PVP ratios were 5:5, 6:4,
7:3, 8:2, 9:1.
2.3. Preparation of the Physical ixtures
For the fourier transfor infrared (FT-IR) measurements the powder physical mixtures of the gel
components (containing furosemide, polymers, and surfactant) were prepared and homogenized by
stirring for 5 min in a porcelain mortar.
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oscillatory rheolog c l tests. The os il atory shear measurements wer performed at amplitude within
the linear region, which was ch sen to 30% within the viscoelas ic region, and the freque cy was in
the ra ge of 0.1–10 s−1. Three parallel measur ments were done with each g l in both ests.
2.5. Electrospinning
The nanofibers were prepared by electrospinning at room temperature (25 ◦C). The gels were put
into syringes, after that, silicon tubes with needles (i tern l dia et r: 1.2) on their ends wer connected
to the syringes. High volt ge was appli d (25 kV) at 15 cm collector-n edle dista ce. Th flow rat
was 0.3 mL/h during the spinning process. The prepared fibers and droplets were dried at room
temperature during t e electrospinning process.
2.6. ATR-FTIR (Attenuated Total Reflectance-Fourier Transform Infrared) Spectroscopy Measurements
The ATR-FTIR spectra of the fibers, physical mixtures and raw substances were measured by
using Jasco FT/IR-4200 spectrophotometer (Jasco Inc., Easton, MD, USA), which was equipped with
Jasco ATR PRO470-H single reflection accessory. The spectra were collected over a wavenumber range
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of 4000 and 1800 cm−1. After 100 scans, the measurements were evaluated with Spectra Manager-II,
Jasco software.
2.7. Scanning Electron Microscopy (SEM) Measurements
The morphology was examined by JEOL 6380LVa (JEOL, Tokyo, Japan) scanning electron
microscope using secondary electron imaging detection method. The collected samples on aluminum
foil were fixed with conductive double-sided carbon adhesive tape, and their surface was covered by
sputtered gold before the measurement. Accelerating voltage (15 kV) was applied, and the working
distance was 10 mm during the examination.
2.8. Statistical Analysis of the Fiber Diameters
Statistical comparisons of samples were conducted using SPSS 20.0 software package (SPSS Inc.,
Chicago, IL, USA). The SEM images were used for the measurement, and the mean diameters were
calculated by using Image J program (https://imagej.nih.gov/nih-image/). Fifty measurements from
the fibrous elements were carried out in each SEM image. Only the fibers were examined, and the
droplets were not considered for the determination of the average diameter size.
3. Results and Discussion
3.1. Rheological Properties
Figure 2 represents the loss (G”)/storage (G’) moduli as a function of HPC-PVP ratio. The results
indicate, as a function of the SEM images, that there is an optimum viscoelastic behavior of
the composite gels, which results in the best fiber forming ability, and thus, more homogeneous
randomly-oriented fibrous mats. Similarly to the previous experiences [21], the scanning electron
microscopic images of the samples revealed that revealed that there exists a viscoelastic range, which
provides an advantageous macrostructural arrangement of the macromolecules for the fiber formation.
The latter can be explained by phenomenon that the prevalent viscoelasticity of the sample could
be disadvantageous from the point of the formation of homogeneous nanostructured fiber elements,
since the electrical forces cannot be effectively transferred to the viscoelastic elongation of the polymer
jets in the course of the fiber formation. The most elastic sample (HPC-PVP = 6:4) resulted the most
homogenous nanofibrous system.
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3.2. ATR-FTIR Analysis
The FT-IR spectra of the raw materials, the physical mixtures and the prepared formulations are
presented in the Figure 3. Furosemide has three characteristic peaks in the range of 3400–3200 cm−1.
The peaks are sulphonamide NH stretching at 3397 cm−1 and 3281 cm−1, and there is a peak of
secondary amine NH stretching at 3349 cm−1, which are in good agreement with previous studies [7].
The Figure 3 clearly indicates similar peaks belonging to the sulphonamide NH stretching, and a
peak of the secondary amine NH stretching, which are missing in the fibrous sample, meanwhile,
these peaks can be distinguished in the physical mixture of the components. In the 1600–500 cm−1
“fingerprint region” of the fibers, the characteristic peaks of the fiber-forming polymers (PVP at
1653 cm−1 NH bending, HPC at 1100 cm−1 C–O stretching) can be identified (indicated in the Figure 3).
The solubilized furosemide complexes are situated in the polymeric chains, thus forming an amorphous
solid dispersion.
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(a) furosemide; (b) HPC EXF; (c) PVP 90F; (d) trolamine; (e) physical mixture (HPC-PVP = 6:4 molar
ratio); (f) furosemide containing fiber of HPC-PVP = 6:4 molar ratio.
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3.3. Morphological Analysis
Along with the changes of the polymer ratio, the corresponding morphology of the electrospun
samples also varied. On the scanning electron microscopic images (Figure 4), nanofibers and
spray-dried droplets were distinguished. In case of images A and B, the fibrous structural elements
are the most dominant, while on images C–E, droplets and randomly oriented fibers can be found, as
well. Along with the increase of the HPC ratio in the composites, more droplets formed in the fibrous
mats. Based on the SEM images, sample B (HPC-PVP = 6:4) can be considered the most homogeneous
fibrous system.
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sample distributions was analyzed by variance, and significant differences found (p < 0.001). Further,
pairwise comparisons using the Bonferroni and Scheffe post hoc tests were conducted. The first sample
(HPC-PVP = 5:5) shows significant difference from the other three (p < 0.001); the other samples are all
normally distributed compared to each other. The results of the statistical analysis are illustrated in the
Figure 5. The statistical evaluation confirmed that a sample of HPC-PVP = 6:4 ratio is the principally
suitable concentration for electrospinning under given preparation conditions, which suggests that
in case of the optimum concentration, the characteristics of the fibers are more predictable than in
other concentrations.
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Figure 5. Distribution of fiber diameters. (A) HPC-PVP = 5:5 molar ratio; average diameter:
618.76 ± 193.617 nm; (B) HPC-PVP = 6:4 molar ratio; average diameter: 443.89 ± 158.376 nm;
(C) HPC-PVP = 7:3 molar ratio; average diameter: 419.43 ± 116.048 nm; (D) HPC-PVP = 8:2 molar
ratio; average diameter: 367.50 ± 153.908 nm.
4. Conclusions
Furosemide loaded HPC-PVP composite nanofibrous systems were prepared successfully by
electrospinni g process. e opti um composition of HPC-PVP fibers was determined based
on the rheologic l ex mi ation of polymeric solutions and the sc i electron microscopic
morphol gical char cterization of the corresponding electrospun samples. This formulation could
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enable the transmucosal amorphous drug delivery of the poorly soluble and permeable drug (BCS IV),
thus improving the oral bioavailability of furosemide, meanwhile, avoiding its first pass metabolism.
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